3393 Total Publications
Initiation of symptomatic medication in Alzheimer's disease clinical trials: Hypothetical versus treatment policy approach
Donohue, MC, Model, F, Delmar, P, Volye, N, Liu‐Seifert, H, Rafii, MS, Aisen, PS and Initiative, AsDN
2020; Journal Alzheimer's & Dementia; vol. 16; no. 5; pp. 797-803;
Multi-atlas image registration of clinical data with automated quality assessment using ventricle segmentation
Dubost, F, Bruijne, M, Nardin, M, Dalca, AV, Donahue, KL, Giese, AK, Etherton, MR, Wu, O, Groot, M, Niessen, W, Vernooij, M, Rost, NS and Schirmer, MD
2020; Journal Med Image Anal; vol. 63; pp. 101698;
Genetic variants and functional pathways associated with resilience to Alzheimer's disease
Dumitrescu, L, Mahoney, ER, Mukherjee, S, Lee, ML, Bush, WS, Engelman, CD, Lu, Q, Fardo, DW, Trittschuh, EH, Mez, J, Kaczorowski, C, Hernandez Saucedo, H, Widaman, KF, Buckley, R, Properzi, M, Mormino, E, Yang, HS, Harrison, T, Hedden, T, Nho, K, Andrews, SJ, Tommet, D, Hadad, N, Sanders, RE, Ruderfer, DM, Gifford, KA, Moore, AM, Cambronero, F, Zhong, X, Raghavan, NS, Vardarajan, B, Pericak-Vance, MA, Farrer, LA, Wang, LS, Cruchaga, C, Schellenberg, G, Cox, NJ, Haines, JL, Dirk Keene, C, Saykin, AJ, Larson, EB, Sperling, RA, Mayeux, R, Bennett, DA, Schneider, JA, Crane, PK, Jefferson, AL and Hohman, TJ
PMID: 7447518
; 2020; Journal Brain; vol. 143; no. 8; pp. 2561-2575;
Patterns of longitudinal cortical atrophy over 3 years in empirically derived MCI subtypes
Edmonds, EC, Weigand, AJ, Hatton, SN, Marshall, AJ, Thomas, KR, Ayala, DA, Bondi, MW and McDonald, CR
2020; Journal Neurology;
MMSE Subscale Scores as Useful Predictors of AD Conversion in Mild Cognitive Impairment
Choe, YM, Lee, BC, Choi, IG, Suh, GH, Lee, DY and Kim, JW
2020; Journal Neuropsychiatr Dis Treat; vol. 16; pp. 1767-1775;
Development and validation of language and visuospatial composite scores in ADNI
Choi, SE, Mukherjee, S, Gibbons, LE, Sanders, RE, Jones, RN, Tommet, D, Mez, J, Trittschuh, EH, Saykin, A, Lamar, M, Rabin, L, Foldi, NS, Sikkes, S, Jutten, RJ, Grandoit, E, Mac Donald, C, Risacher, S, Groot, C, Ossenkoppele, R and Crane, PK
PMCID:7718716
; 2020; Journal Alzheimers Dement (N Y); vol. 6; no. 1; pp. e12072;
MicroRNA-298 reduces levels of human amyloid-beta precursor protein (APP), beta-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties
Chopra, N, Wang, RZ, Maloney, B, Nho, K, Beck, JS, Pourshafie, N, Niculescu, A, Saykin, AJ, Rinaldi, C, Counts, SE and Lahiri, DK
2020; Journal Molecular Psychiatry;
Multimodal in vivo and postmortem assessments of tau in Lewy body disorders
Coughlin, DG, Phillips, JS, Roll, E, Peterson, C, Lobrovich, R, Rascovsky, K, Ungrady, M, Wolk, DA, Das, S, Weintraub, D, Lee, EB, Trojanowski, JQ, Shaw, LM, Vaishnavi, S, Siderowf, A, Nasrallah, IM, Irwin, DJ and McMillan, CT
2020; Journal Neurobiol Aging; vol. 96; pp. 137-147;
A second X chromosome contributes to resilience in a mouse model of Alzheimer's disease
Davis, EJ, Broestl, L, Abdulai-Saiku, S, Worden, K, Bonham, LW, Minones-Moyano, E, Moreno, AJ, Wang, D, Chang, K, Williams, G, Garay, BI, Lobach, I, Devidze, N, Kim, D, Anderson-Bergman, C, Yu, GQ, White, CC, Harris, JA, Miller, BL, Bennett, DA, Arnold, AP, De Jager, PL, Palop, JJ, Panning, B, Yokoyama, JS, Mucke, L and Dubal, DB
2020; Journal Science Translational Medicine; vol. 12; no. 558;
